Browsing by Author Dalton, JP

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 31 to 50 of 108< previous   next >
Issue DateTitleAuthor(s)
1-May-2011A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptidesRobinson, MW; Donnelly, S; Hutchinson, AT; To, J; Taylor, NL; Norton, RS; Perugini, MA; Dalton, JP
30-Sep-2003Fasciola hepatica cathepsin L-like proteases: Biology, function, and potential in the development of first generation liver fluke vaccinesDalton, JP; Neill, SO; Stack, C; Collins, P; Walshe, A; Sekiya, M; Doyle, S; Mulcahy, G; Hoyle, D; Khaznadji, E; Moiré, N; Brennan, G; Mousley, A; Kreshchenko, N; Maule, AG; Donnelly, SM
3-Apr-2015The Fasciola hepatica genome: Gene duplication and polymorphism reveals adaptation to the host environment and the capacity for rapid evolutionCwiklinski, K; Dalton, JP; Dufresne, PJ; La Course, J; Williams, DJL; Hodgkinson, J; Paterson, S
1-Oct-2016Fasciola hepatica surface tegument: Glycoproteins at the interface of parasite and hostRavida, A; Cwiklinski, K; Aldridge, AM; Clarke, P; Thompson, R; Gerlach, JQ; Kilcoyne, M; Hokke, CH; Dalton, JP; O'Neill, SM
1-Jan-2015Fasciola hepatica vaccine: We may not be there yet but we're on the right roadMolina-Hernández, V; Mulcahy, G; Pérez, J; Martínez-Moreno, Á; Donnelly, S; O'Neill, SM; Dalton, JP; Cwiklinski, K
1-Apr-2012Fasciola hepatica virulence-associated cysteine peptidases: A systems biology perspectiveMcVeigh, P; Maule, AG; Dalton, JP; Robinson, MW
1-Jan-2013Fasciola hepatica: The therapeutic potential of a worm secretomeRobinson, MW; Dalton, JP; O'Brien, BA; Donnelly, S
16-Feb-2012Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, Plasmodium falciparumPoreba, M; McGowan, S; Skinner-Adams, TS; Trenholme, KR; Gardiner, DL; Whisstock, JC; To, J; Salvesen, GS; Dalton, JP; Drag, M
1-Feb-2010Fluorobenzoyl dipeptidyl derivatives as inhibitors of the Fasciola hepatica cysteine protease cathepsin L1Moran, BW; Anderson, FP; Ruth, DM; Fágáin, CO; Dalton, JP; Kenny, PTM
1-Oct-2004Glycosidase activity in the excretory-secretory products of the liver fluke, Fasciola hepaticaIrwin, JA; Morrissey, PEW; Ryan, JP; Walshe, A; O'Neill, SM; Carrington, SD; Matthews, E; Fitzpatrick, E; Mulcahy, G; Corfield, AP; Dalton, JP
1-Nov-2008Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophagesDonnelly, S; Stack, CM; O'Neill, SM; Sayed, AA; Williams, DL; Dalton, JP
1-Nov-2012A helminth cathelicidin-like protein suppresses antigen processing and presentation in macrophages via inhibition of lysosomal vATPaseRobinson, MW; Alvarado, R; To, J; Hutchinson, AT; Dowdell, SN; Lund, M; Turnbull, L; Whitchurch, CB; O'Brien, BA; Dalton, JP; Donnelly, S
29-Jan-2010Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3Donnelly, S; O'Neill, SM; Stack, CM; Robinson, MW; Turnbull, L; Whitchurch, C; Dalton, JP
1-Jan-2013Helminth defence molecules-immunomodulators designed by parasites!Robinson, MW; Donnelly, S; Dalton, JP
1-Dec-2008Helminth pathogen cathepsin proteases: it's a family affairRobinson, MW; Dalton, JP; Donnelly, S
1-Jan-2003Helminth vaccines: From mining genomic information for vaccine targets to systems used for protein expressionDalton, JP; Brindley, PJ; Knox, DP; Brady, CP; Hotez, PJ; Donnelly, S; O'Neill, SM; Mulcahy, G; Loukas, A
19-Apr-2004Helminths at mucosal barriers - Interaction with the immune systemMulcahy, G; O'Neill, S; Donnelly, S; Dalton, JP
19-Dec-2011How pathogen-derived cysteine proteases modulate host immune responsesDonnelly, S; Dalton, JP; Robinson, MW
29-Nov-2007Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compoundsSkinner-Adams, TS; Lowther, J; Teuscher, F; Stack, CM; Grembecka, J; Mucha, A; Kafarski, P; Trenholme, KR; Dalton, JP; Gardiner, DL
1-Jan-2014Identification of potent and selective inhibitors of the plasmodium falciparum M18 aspartyl aminopeptidase (PfM18AAP) of human malaria via high-throughput screeningSpicer, T; Fernandez-Vega, V; Chase, P; Scampavia, L; To, J; Dalton, JP; Da Silva, FL; Skinner-Adams, TS; Gardiner, DL; Trenholme, KR; Brown, CL; Ghosh, P; Porubsky, P; Wang, JL; Whipple, DA; Schoenen, FJ; Hodder, P